HCCscreenTM is powered by Genetron Health’s innovative and proprietary Mutation Capsule technology, which enables detection of multiple methylation alterations in parallel with mutations in cell-free DNA from peripheral blood specimens. Currently, HCCscreen is being tested in its ongoing prospective study with 4,500 HBsAg+ individuals.